EV Biologics Inc (YECO)
0.6021
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
EV Biologics Total Assets (Quarterly): 31.82M for Dec. 31, 2017
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 31.82M |
| December 31, 2016 | 33.93M |
| September 30, 2016 | 36.10M |
| June 30, 2016 | 36.44M |
| March 31, 2016 | 95.91M |
| December 31, 2015 | 89.74M |
| Date | Value |
|---|---|
| September 30, 2015 | 90.20M |
| June 30, 2015 | 77.60M |
| March 31, 2015 | 71.74M |
| December 31, 2014 | 67.86M |
| September 30, 2014 | 77.70M |
| June 30, 2014 | 69.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.89M |
| Shareholders Equity (Quarterly) | 2.930M |